For subscribers
Commentary
Weighing the pros and cons of investing in healthcare
Sign up now: Get ST's newsletters delivered to your inbox
Last month, Danish pharmaceutical firm Novo Nordisk became Europe’s most valuable company.
PHOTO: REUTERS
Larenza Ng and Niquole Sim
Follow topic:
SINGAPORE – Ozempic, Wegovy and Novo Nordisk are not words that most people would have recognised a year ago.
These days, all three have leapt into the limelight as weight-loss drugs have become the rage, with Hollywood celebrities, social media influencers and even billionaire Elon Musk reportedly using them.
